SCHEMBL8430229

SCHEMBL8430229

COc1ccc(F)c(-c2cnc(NN)cn2)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM1A O60341 2/20 0.52
NPC1 O15118 5/20 0.46
RAB9A P51151 5/20 0.46
DHODH Q02127 1/20 0.43
PIM1 P11309 1/20 0.39
BACE1 P56817 3/20 0.38
CTSD P07339 1/20 0.38
IDH2 P48735 1/20 0.38
MAPT P10636 1/20 0.37
CRHBP P24387 1/20 0.37
CRHR2 Q13324 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
APP P05067 1/20 0.36
CASP3 P42574 1/20 0.36
SENP7 Q9BQF6 1/20 0.36
POLQ O75417 1/20 0.36
ALOX5AP P20292 3/20 0.36
FEN1 P39748 3/20 0.36
PDE2A O00408 1/20 0.36
PDE6D O43924 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8430167 0.78 KDM1A (0.55) KDM1ANPC1RAB9ADHODHPIM1
SCHEMBL15990506 0.75 KDM1A (0.49) KDM1ANPC1RAB9ADHODHPIM1
SCHEMBL2403919 0.74 KDM1A (0.50) KDM1ANPC1RAB9ADHODHPIM1
SCHEMBL2403768 0.73 KDM1A (0.53) KDM1ANPC1RAB9ADHODHPIM1
SCHEMBL27322683 0.71 CCR1 (0.63) KDM1ANPC1RAB9ADHODHPIM1
SCHEMBL8428280 0.69 KDM1A (0.49) KDM1ANPC1RAB9ADHODHPIM1
SCHEMBL20341731 0.69 KDM1A (0.52) KDM1ANPC1RAB9ADHODHPIM1
SCHEMBL15990505 0.69 KDM1A (0.55) KDM1ANPC1RAB9ADHODHPIM1
SCHEMBL21835703 0.69 CYP1A2 (0.51) ALOX5APFEN1
SCHEMBL7696178 0.69 KDM1A (1.00) KDM1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5910590-A INTERACTS WITH GABA BINDING SITE (THE BENZODIAZEPINE RECEPTOR); TREATMENT OF ANXIETY, SEIZURE AND SLEEP DISORDERS, ENHANCES ALERTNESS AND TREATMENT OF BENZODIAZEPINE OVERDOSES NEUROGEN CORPORATION (US) 1999-06-08 US disclosed
US-5668283-A Certain aryl substituted pyrrolopyrazines; a new class of GABA brain receptor ligands NEUROGEN CORPORATION (US) 1997-09-16 US disclosed
US-5606059-A USEFUL IN THE DIAGNOSIS AND TREATMENT OF ANXIETY, SLEEP AND SEIZURE DISORDERS, OVERDOSE WITH BENZODIAZEPINE TYPE DRUGS AND THE ENHANCEMENT OF ALERTNESS NEUROGEN CORPORATION (US) 1997-02-25 US disclosed
WO-1994011374-A1 CERTAIN ARYL SUBSTITUTED PYRROLOPYRAZINES; A NEW CLASS OF GABA BRAIN RECEPTOR LIGANDS NEUROGEN CORPORATION (US) 1994-05-26 WO disclosed
US-5286860-A Certain aryl substituted pyrrolopyrazines; a new class of GABA brain receptor ligands NEUROGEN CORPORATION (US) 1994-02-15 US disclosed